Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a…
News
CorMedix Inc. Announces Scientific Advisory Board to Support Commercialization and Pipeline Development
BERKELEY HEIGHTS, N.J., April 07, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Impel NeuroPharma To Present At The 21st Annual Needham Healthcare Conference
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) — Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company…
Neoleukin Therapeutics to Present at Canaccord Genuity Horizons in Oncology Conference
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Rubius Therapeutics to Host Investor Webcast to Discuss Updated Clinical Data at AACR from the Ongoing Monotherapy Phase 1 Arm of the Phase 1/2 Clinical Trial of RTX-240 in Patients with Advanced Solid Tumors on April 8, 2022, at 1:15 PM ET
CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage…
VYNE Therapeutics Announces Positive Phase 1b Efficacy Data for FMX114 from Phase 1b/2a Trial for the Treatment of Mild-to-Moderate Atopic Dermatitis
At week 2, FMX114 demonstrated a statistically significant reduction in both absolute and percent change…
Propella Therapeutics Announces Licensing Agreement with Jiangsu Aosaikang Pharmaceutical Co. Ltd. (ASK Pharm) for Development and Commercial Rights to CGS-200-5 in Greater China
Propella to Receive Upfront Payment, Regulatory and Sales Milestones, and Royalties Phase 2 Study of…
Lexicon Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference
THE WOODLANDS, Texas, April 07, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today…
LianBio Appoints Wei Wei Chen to Board of Directors
SHANGHAI and PRINCETON, N.J., April 07, 2022 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology…
Apexigen Announces That New Data From Phase 2 Trial Evaluating its CD40 Antibody Sotigalimab in Combination With Pembrolizumab in Patients With Metastatic Melanoma Will Be Presented at the AACR Annual Meeting 2022
Data to be featured in an oral presentation on April 12, 2022 at 3:35pm (CDT)…
Harpoon Therapeutics to Participate in Canaccord Genuity Horizons in Oncology Virtual Conference
SOUTH SAN FRANCISCO, Calif., April 07, 2022 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP),…
Verrica Pharmaceuticals Announces Participation in the 21st Annual Needham Virtual Healthcare Conference
WEST CHESTER, Pa., April 07, 2022 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA),…
Agile Therapeutics® Announces Poster Presentation at the 2022 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists (ACOG)
The abstract was accepted by ACOG and will be presented from May 4th – May…
Aptose Announces Executive Management Changes
─ Appoints Philippe Ledru as Chief Commercial Officer ─ ─ Announces resignation of CFO/CBO Jotin…
VectivBio Reports Full Year 2021 Financial Results and Provides Business Update
Significant Progress Across Multiple Programs with Key Upcoming Catalysts Beginning H2 2022 STARS Phase 3…
XORTX Announces Grant of US Patent
Patent supporting Autosomal Dominant Polycystic Kidney Disease Granted – XRx-008 Program CALGARY, Alberta, April 07,…
ZOLEO Inc. Introduces Industry-Leading Progressive SOS
Uniquely, ZOLEO® users now receive continuous step-by-step updates during emergency incidents Progressive SOS on the…
Austin Business Journal Names Gotransverse to Top 100 Tech Employers List
SaaS provider of order-to-cash solutions makes list two years running AUSTIN, Texas, April 07, 2022…
Sopheon Boosts Innovation System with Real-time Information and Collaboration Enhancements  Â
With improved transparency and communication capabilities, the latest Accolade release delivers fast, fact-based decision making…
Voxtur to Provide Attorney Opinion Letters on Fannie Mae Loans
TORONTO and TAMPA, Fla., April 07, 2022 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR;…